| PD-1/PD-L1 | programmed death 1/ligand 1 |
| CTLA-4 | cytotoxic T-lymphocyte antigen 4 |
| irAE | immune-related adverse event |
| CTCAEv5 | Common Terminology Criteria for Adverse Events version 5 |
| SIT | selective immunosuppressive therapy |
| PD-1/PD-L1 | programmed death 1/ligand 1 |
| CTLA-4 | cytotoxic T-lymphocyte antigen 4 |
| irAE | immune-related adverse event |
| CTCAEv5 | Common Terminology Criteria for Adverse Events version 5 |
| SIT | selective immunosuppressive therapy |